UA102081C2 - Универсальная вакцина для лечения и профилактики болезни лайма для применения в ветеринарии и способ ее производства - Google Patents

Универсальная вакцина для лечения и профилактики болезни лайма для применения в ветеринарии и способ ее производства

Info

Publication number
UA102081C2
UA102081C2 UAA201007218A UAA201007218A UA102081C2 UA 102081 C2 UA102081 C2 UA 102081C2 UA A201007218 A UAA201007218 A UA A201007218A UA A201007218 A UAA201007218 A UA A201007218A UA 102081 C2 UA102081 C2 UA 102081C2
Authority
UA
Ukraine
Prior art keywords
prophylaxis
treatment
lyme disease
veterinary use
manufacture
Prior art date
Application number
UAA201007218A
Other languages
English (en)
Ukrainian (uk)
Inventor
Владимир ВРЗАЛ
Либор БИТТНЕР
Иржи НЕПЕРЕНИ
Йосеф ХУМЕЛА
Original Assignee
Байовета, А.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байовета, А.С. filed Critical Байовета, А.С.
Publication of UA102081C2 publication Critical patent/UA102081C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Изобретение относится к универсальной вакцине для лечения и профилактики болезни Лайма для применения в ветеринарии на основе цельноклеточной бактериальной вакцины или бактериальных лизатов, или очищенных препаратов, причем вакцина включает три наиболее патогенных геновидаи, каждый из которых содержит одновременно два иммуногенных протективных белка внешней мембраны: OspA и OspC.
UAA201007218A 2007-11-14 2008-10-21 Универсальная вакцина для лечения и профилактики болезни лайма для применения в ветеринарии и способ ее производства UA102081C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20070791A CZ301244B6 (cs) 2007-11-14 2007-11-14 Univerzální vakcína k lécbe a prevenci Lymeské borreliózy pro humánní a veterinární použití a zpusob její výroby
PCT/CZ2008/000130 WO2009062454A2 (en) 2007-11-14 2008-10-21 Universal vaccine for the treatment and prophylaxis of lyme disease for human and veterinary use and method of its manufacture

Publications (1)

Publication Number Publication Date
UA102081C2 true UA102081C2 (ru) 2013-06-10

Family

ID=40600158

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201007218A UA102081C2 (ru) 2007-11-14 2008-10-21 Универсальная вакцина для лечения и профилактики болезни лайма для применения в ветеринарии и способ ее производства

Country Status (5)

Country Link
EP (1) EP2219670A2 (ru)
CZ (1) CZ301244B6 (ru)
RU (1) RU2472525C2 (ru)
UA (1) UA102081C2 (ru)
WO (1) WO2009062454A2 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ301244B6 (cs) * 2007-11-14 2009-12-16 Bioveta, A.S. Univerzální vakcína k lécbe a prevenci Lymeské borreliózy pro humánní a veterinární použití a zpusob její výroby
CZ301548B6 (cs) * 2008-08-20 2010-04-14 Bittner@Libor Univerzální preparát ke zvýšení obranyschopnosti, prevenci, profylaxi a lécbe Lymeské boreliózy pro humánní a veterinární použití, zpusob jeho výroby a použití
PL223175B1 (pl) 2012-10-22 2016-10-31 Inst Chemii Bioorganicznej Polskiej Akademii Nauk Szczepionka przeciw boreliozie, konstrukt genetyczny, rekombinowane białko, sposób otrzymywania konstruktu genetycznego, sposób otrzymywania szczepionki, sposób otrzymywania rekombinowanych białek, zastosowanie rekombinowanych białek do wytwarzania szczepionki przeciwko boreliozie

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872550B1 (en) * 1991-07-11 2005-03-29 Baxter Vaccine Ag Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
RU2102081C1 (ru) * 1991-07-11 1998-01-20 Иммуно АГ Иммуногенная композиция против боррелиоза лайма, способ иммунизации млекопитающего против боррелиоза лайма, способ получения белка pc borrelia burgdorferi, диагностический агент для обнаружения b.burgdorferi и способ обнаружения антител к b.burgdorferi
SK279968B6 (sk) * 1993-04-29 1999-06-11 Immuno Aktiengesellschaft Imunogénny prostriedok, sekvencia rekombinantnej d
US7008625B2 (en) * 1993-11-01 2006-03-07 Research Foundation Of The State University Of New York Recombinant constructs of Borrelia burgdorferi
EP0757556B1 (en) * 1994-04-11 2006-06-14 Wyeth Holdings Corporation Borrelia burgdorferi bacterin
US5846946A (en) * 1996-06-14 1998-12-08 Pasteur Merieux Serums Et Vaccins Compositions and methods for administering Borrelia DNA
NZ576564A (en) * 2006-11-03 2012-03-30 Schering Plough Ltd Canine lyme disease vaccine
CZ301244B6 (cs) * 2007-11-14 2009-12-16 Bioveta, A.S. Univerzální vakcína k lécbe a prevenci Lymeské borreliózy pro humánní a veterinární použití a zpusob její výroby

Also Published As

Publication number Publication date
CZ301244B6 (cs) 2009-12-16
WO2009062454A3 (en) 2009-07-16
EP2219670A2 (en) 2010-08-25
RU2472525C2 (ru) 2013-01-20
CZ2007791A3 (cs) 2009-05-27
WO2009062454A2 (en) 2009-05-22
RU2010123897A (ru) 2011-12-20

Similar Documents

Publication Publication Date Title
WO2008124647A3 (en) Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof
SG160329A1 (en) Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
SG158145A1 (en) Vaccines against chlamydial infection
DE69941454D1 (de) Impfstoff gegen staphylokokken-vergiftung
WO2008143747A3 (en) Methods and apparatus for the use of slice groups in decoding multi-view video coding (mvc) information
MX2010004482A (es) Anticuerpos anti-proteina g vsr.
EP4245320A3 (en) Methods and compositions for immune protection against extra-intestinal pathogenic e. coli
EA200870129A1 (ru) Человеческие антитела против il-23, композиции, способы и применение
WO2007092496A3 (en) 7,9-dihydro-purin-8-one and related analogs as hsp90-inhibitors
ME00982B (me) Oslabljeni sojevi bakterije mycoplasma gallisepticum
WO2016115310A3 (en) Device for accommodating surgical tool prior to and during medical procedures
WO2012135701A3 (en) Compositions and methods for the detection of anaplasma platys
WO2009077577A3 (en) Vaccine antigens from piscirickettsia salmonis
UA102081C2 (ru) Универсальная вакцина для лечения и профилактики болезни лайма для применения в ветеринарии и способ ее производства
WO2016118766A8 (en) Nmr methods and systems for the rapid detection of tick-borne pathogens
MX370869B (es) Abrazaderas gemelas.
EP4137506A4 (en) COMPOSITION OF AFRICAN SWINE FEVER VACCINE
AU2001281145A1 (en) Recombinant constructs of borrelia burgdorferi
ATE543511T1 (de) Attenuierte lebendimpfstoffe gegen pleuropneumonie bei schweinen
MX2010003220A (es) Proteinas inmunogenicas de membrana exterior derivada de genoma de leptospira y composiciones y metodos basados en las mismas.
Rudakova et al. Penyevskaya NA Genospecies Diversity of Borrelia in Ixodes Ticks of the West Siberia
WO2007098717A3 (es) Antígenos vacunales quiméricos contra el virus de la peste porcina clásica
WO2006046017A8 (en) Vaccine and nucleic acids capable of protecting poultry against colonisation by campylobacter
BRPI0921371A2 (pt) Células-tronco para uso terapêutico que são derivados de monócito humano, e método para induzir as mesmas.
EA201491668A1 (ru) Вакцины и способы для лечения болезни лайма у собак